In vivo fluence rate and fractionation effects on tumor response and photobleaching: Photodynamic therapy with two photosensitizers in an orthotopic rat tumor model

Cancer Research

Volumn 59, Issue 24, 1999, Pages 6164-6170

  Iinuma, Seiichi ^a   Schomacker, Kevin T ^a   Wagnieres, Georges ^a   Rajadhyaksha, Milind ^a   Bamberg, Michael ^a   Momma, Tetsuo ^a   Hasan, Tayyaba ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ANIMAL CELL; ARTICLE; BLADDER TUMOR; BLEACHING; CELL DESTRUCTION; CONTROLLED STUDY; DOSIMETRY; HYPOXIC CELL; NONHUMAN; OXYGEN CONSUMPTION; PHOTODEGRADATION; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; RAT;

AMINOLEVULINIC ACID; ANIMALS; DERMATITIS, PHOTOTOXIC; DISEASE MODELS, ANIMAL; FEMALE; LIGHT; MICROSCOPY, FLUORESCENCE; NEOPLASM TRANSPLANTATION; NIACINAMIDE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; RATS, INBRED F344; SPECTROMETRY, FLUORESCENCE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0033572448     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. Photodynamic therapy., J. Natl. Cancer Inst. 90: 889-905, 1998.
2. Hasan, T., and Parrish, J. A. Photodynamic Therapy of Cancer, in: J. F. Holland, E. Frei, III, R. C. Bast, Jr., D. W. Kufe, D. L. Morton, and R. R. Weichselbaum (eds.), Cancer Medicine, Ed. 4, pp. 739-751. Baltimore: Williams & Wilkins, 1996.
3. Kiyoyushi, F., Masahiro, F., Harubumi, K., Takeshi, H., Kaoru, K., Nagahisa, K., Yoko, K., Nobuhide, T., Tetsuya, O., Chimori, K., Hiromi, W., and Yoshihiro, H. A prospective Phase II study on photodynamic therapy with Photofrin for centrally located early-stage lung cancer. J. Clin. Oncol., 11: 1852-1857, 1993.
4. Gomer, C. J. Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem. Photobiol., 54: 1093-1107, 1991.
5. Henderson, B. W., and Dougherty, T. J. How does photodynamic therapy work? Photochem. Photobiol., 55: 145-157, 1992.
6. Berenbaum, M. C., Akande, S. L., Bonnet, R., Kaur, H., Ioannou, S., White, R. D., and Winfield, U. J. Meso-tetra(hydroxyphenyl)-porphyrins, a new class of potent tumour photosensitizers with favourable selectivity. Br. J. Cancer, 54:717-725, 1986.
7. Duska, L., Hamblin, M. R., Miller, J. L., and Hasan, T. Combination photoimmunotherapy and cisplatin: cytotoxic effects on human ovarian cancer ex vivo. J. Natl. Cancer Inst., 91: 1557-1563, 1999.
8. Hasan, T. Photosensitizer delivery mediated by macromolecular carrier systems. In: B. W. Henderson and T. J. Dougherty (eds.), Photodynamic Therapy: Basic Principles and Clinical Applications, pp. 187. New York: Marcel Dekker, 1992.
9. Bachor, R., Shea, C. R., Gillies, R., and Hasan, T. Photosensitized destruction of human bladder carcinoma cells treated with chlorin-e6 conjugated microspheres. Proc. Natl. Acad. Sci. USA, 88: 1580-1584, 1991.
10. Henderson, B. W., and Fingar, V. H. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochem. Photobiol., 49: 299-304, 1989.
11. Gibson, S. L., Van Der Meid, K. R., Murant, R. S., Raubertas, R. F., and Hilf, R. Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas. Cancer Res., 50: 7236-7241, 1990.
12. Sitnik, T. M., and Henderson, B. W. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Photochem. Photobiol., 67: 462-466, 1998.
13. Tromberg, B. J., Orenstein, A., Kimel, S., Barker, S. J., Hyatt, J., Nelson, J. S., and Berns, M. W. In vivo tumor oxygenation tension measurements for the evaluation of the efficacy of photodynamic therapy. Photochem. Photobiol., 52: 375-385, 1990.
14. Sitnik, T. M., Hampton, J. A., and Henderson, B. W. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br. J. Cancer, 77: 1382-1394, 1998.
15. Zilberstein, J., Bromberg, A., Frantz, A., Rosenbach-Belkin, V., Kritzmann, A., Pferfermann, R., Salomon, Y., and Scherz, A. Light-dependent oxygen consumption in bacteriochlorophyll-serine-treated melanoma tumors: on-line determination using a tissue-inserted oxygen microsensor. Photochem. Photobiol., 65: 1012-1019, 1997.
16. Foster, T. H., Murant, R. S., Bryant, R. G., Knox, R. S., Gibson, S. L., and Hilf, R. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res. 126: 296-303, 1991.
17. Iinuma, S., Farshi, S. S., Ortel, B., and Hasan, T. A mechanistic study of cellular photodestruction with 5-aminolevulinic acid-induced porphyrin. Br. J. Cancer, 70: 21-28, 1994.
18. Fukuda, H., Casas, A., Chueke, F., Paredes, S., and Batlle, A. M. Photodynamic action of endogenously synthesized porphyrins from aminolevulinic acid, using a new model for assaying the effectiveness of tumoral cell killing. Int. J. Biochem., 25: 1395-1398, 1993.
19. Malik, Z., Ehrenberg, B., and Faraggi, A. Inactivation of erythrocytic, lymphocytic and myelocytic leukemic cells by photoexcitation of endogenous porphyrins. J. Photochem. Photobiol. B, 4: 195-205, 1989.
20. Divaris, D. X., Kennedy, J. C., and Pottier, R. H. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized Protoporphyrin IX fluorescence. Am. J. Pathol., 136: 891-897, 1990.
21. Kennedy, J. C., Pottier, R. H., and Pross, D. C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B, 6: 143-148, 1990.
22. Cairnduff, F., Stringer, M. R., Hudson, E. J., Ash, D. V., and Brown, S. B. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary cancer. Br. J. Cancer, 69: 605-608, 1994.
23. Bedwell, J., MacRobert, A. J., Phillips, D., and Bown, S. G. Fluorescence distribution and photodynamic effect of ALA-induced PpIX in the DMH rat colonie tumor model. Br. J. Cancer, 65: 818-824, 1992.
24. Loh, C. S., Bedwell, J., MacRobert, A. J., Kransner, N., Phillips, D., and Bown, S. G. Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminum phthalocyanine and 5-aminolaevulinic acid. Br. J. Cancer, 66: 452-462, 1992.
25. Loh, C. S., MacRobert, A. J., Bedwell, J., Regula, J., Kransner, N., and Bown, S. G. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br. J. Cancer, 68: 41-51, 1993.
26. Allison, B. A., Waterfield, E., Richter, A. M., and Levy, J. G. The effect of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochem. Photobiol., 54: 709-715, 1991.
27. Bachor, R., Flotte, T., Scholtz, M., Dretler, S., and Hasan, T. Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model. J. Urol., 147: 1404-1410, 1992.
28. Ibrahiem, E. H., Nigam, V. N., Brailovsky, C. A., Madarnas, P., and Elhilali, M. Orthotopic implantation of primary N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder cancer in bladder submucosa: an animal model for bladder cancer study. Cancer Res., 43: 617-622, 1983.
29. Henderson, B. W., Waldow, S. M., Mang, T. S., Potter, W. R., Malone, P. B., and Dougherty, T. J. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res., 45: 572-576, 1985.
30. Frisoli, J. K., Tudor, E. G., Flotte, T. J., Hasan, T., Deutsch, T. F., and Schomacker, K. T. Pharmacokinetics of a fluorescent drug using laser-induced fluorescence. Cancer Res., 53: 5954-5961, 1993.
31. Henderson, B. W. Probing the effects of photodynamic therapy through in vivo-in vitro methods. In: D. Kessel (ed.), Photodynamic Therapy of Neoplastic Disease, pp. 169-188. Boston, MA: CRC Press, 1990.
32. Foster, T. H., Hartley, D. F., Nichols, M. G., and Hilf, R. Fluence rate effects in photodynamic therapy of multicell tumor spheroids. Cancer Res., 53: 1249-1254, 1993.
33. Greene, G. F., Kitadai, Y., Pettaway, C. A., von Eschenbach, A. C., Bucana, C. D., and Fidler, I. J. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am. J. Pathol., 150: 1571-1582, 1997.
34. Georgakoudi, I., Nichols, M. G., and Foster, T. H. The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry. Photochem. Photobiol., 65; 135-144, 1997.
35. Georgakoudi, I., and Foster, T. H. Singlet oxygen- versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry. Photochem. Photobiol., 67: 612-625, 1998.
36. Korbelik, M., and Frosi, G. Cellular levels of photosensitizers in tumors: the role of proximity to the blood supply. Br. J. Cancer, 70: 604-610, 1994.
37. Pogue, B. W., and Hasan, T. A theoretical study of light fractionation and dose-rate effects in photodynamic therapy. Radiat. Res., 147: 551-559, 1997.
38. Gibson, S. L., Foster, T. H., Feins, R. H., Raubertas, R. F., Fallon, M. A., and Hilf, R. Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice. Br. J. Cancer, 69: 473-481, 1994.
39. Lee, I., Boucher, Y., and Jain, R. K. Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications. Cancer Res., 52: 3237-3240, 1992.
40. Kelleher, D. K., and Vaupel, P. W. Nicotinamide exerts different acute effects on microcirculatory function and tissue oxygenation in rat tumors. Int. J. Radiat. Oncol. Biol. Phys., 26: 95-102, 1993.
41. Chaplin, D. J., Horsman, M. R., and Trotter, M. J. Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor. J. Natl. Cancer Inst., 82: 672-676, 1990.
42. Fingar, V. H., Mang, T. S., and Henderson, B. W. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbon breathing in mice. Cancer Res., 48: 3350-3354, 1988.
43. Shea, C. R., Hefetz, Y., Gillies, R., Wimberly, J., Dalickas, G., and Hasan, T. Mechanistic investigations of doxycycline photosensitization by picosecond-pulsed and continuous wave laser irradiation of cells in culture. J. Biol. Chem., 265; 5977-5982, 1990.
44. Gillies, R., Kollias, N., Hasan, T., and Diddens, H. Spectral characterization of the benzoporphyrin derivative monoacid ring-A formed in fetal calf solutions during irradiation with 694 nm continuous-wave radiation. J. Photochem. Photobiol. B, 33: 87-90, 1996.
45. Aveline, B., Hasan, T., and Redmond, R. W. Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA). Photochem. Photobiol., 59: 328-335, 1994.
46. Robinson, D. J., de Bruijn, H. S., van der Veen, N., Stringer, M. R., Brown, S. B., and Star, W. M. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem. Photobiol., 67: 140-149, 1998.
47. Robinson, D. J., de Bruijn, H. S., van der Veen, N., Stringer, M. R., Brown, S. B., and Star, W. M. Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin. Photochem. Photobiol., 69: 61-70, 1999.
48. Cox, G. S., Bobillier, G., and Whitten, D. G. Photooxidation and singlet oxygen sensitization by protoporphyrin IX and its photooxidation products. Photochem. Photobiol., 36: 401-407, 1982.
49. Sorensen, R., Iani, V., and Moan, J. Kinetics of photobleaching of protoporphyrin IX in the skin of nude mice exposed to different fluence rates of red light., Photochem. Photobiol., 68: 835-840, 1998.
50. Goldman, R. A., Hasan, T., Hall, C. C., Strycharz, W. A., and Cooperman, B. S. Photoincorporation of tetracycline into Escherichia coli ribosomes. Identification of the major proteins photolabeled by native tetracycline and photoproducts and implications of the inhibitory action of tetracycline on protein synthesis. Biochemistry, 22: 359-368, 1983.
51. Hasan, T., Allen, M., and Cooperman, B. S. Anhydrotetracycline is a major product of tetracycline photolysis. J. Org. Chem., 50: 4604-4606, 1986.
52. Prahl, S. Light transport in tissue, Ph.D. dissertation, University of Texas, Austin, 1988.
53. Van Germert, M. J. C., Jacques, S. L., Sterenborg, H. J. C. M., and Star, W. M. Skin optics, I.E.E.E. Trans. Biomed. Eng., 36: 1146-1154, 1989.
54. Cheong, W. F., Prahl, S., and Welch, A. J. A review of the optical properties of biological tissues. Inst. Electr. Electron. Eng. J. Quantum Electron., 26; 2166-2184, 1990.
55. Farrell, T. J., and Patterson, M. S. A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the noninvasive determiation of tissue optical properties in vivo. Med. Phys., 19: 879-888, 1992.